Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...

Founded by former IT specialist Conor Butts, the company is now zeroing in on creating a more comfortable screening process for pediatric patients.

The Epilepsy Program at University of Utah Health is dedicated to improving the lives of people with epilepsy through innovative research and clinical trials. Our experts are at the forefront of ...

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...

Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

Researchers from Inserm and Grenoble Alpes University (UGA) have discovered a new therapeutic avenue for combating drug-resistant epilepsies. Fractionated administration of microbeam X-rays induces ...

Scientists are moving toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving ...

Autoimmune epilepsy is a newly defined group of conditions characterized by recurrent seizures associated with autoimmunity. Cancer and infections are two potential triggers. Epilepsy is a seizure ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...